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the heart in the surgically treated patients was achieved
in a different manner depending on age and sex of the
individual patient and the individual surgeon’s prefer-
ence. Third, the difference in shunt size may have influ-
enced the incidence of postoperative atrial flutter/fibril-
lation. Fourth, the length of hospital stay after closure
may vary from country to country, so that our result of
a significant difference in length of hospital stay after
surgery cannot necessarily be extrapolated to the med-
ical systems of other countries. 
This is a nonrandomized study with evidence of sig-
nificant patient selection bias, which limits the possi-
bility of comparing the 2 strategies and may influence
our conclusions.
Conclusions
Despite the described limitations of this study, we
conclude that Amplatzer device closure of ASDs is
preferable to surgical closure whenever the anatomy of
the ASD is suitable; closure rates of nonoperative ASD
occlusion are identical to those of surgical closure, and
complications with the 2 methods are comparable. We
believe that transcatheter closure of ASDs with the
Amplatzer septal occluder is a definite alternative to
surgery in an increasing number of selected patients.
We thank Dr Ulrich Mansmann of the Institute of Medical
Statistics Epidemiology and Informatics at the Free
University of Berlin for assistance with the statistical evalua-
tion of the paper and Silke Uhlmann for aid in finishing the
manuscript.
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Commentary
Interventional catheter device closure of secundum
atrial septal defects (ASDs) has become consistently
feasible in recent years. Although it is logical that this
technique might offer advantages over surgical closure,
no real comparison of the 2 methods has been previ-
The Journal of Thoracic and
Cardiovascular Surgery
Volume 118, Number 4
Berger et al   679
ously reported. As current catheter devices were being
developed and refined, traditional surgical approaches
were also being altered by the development of less
invasive techniques such as partial sternotomies and
much smaller skin incisions. Berger and colleagues
have evaluated a consecutive series of 102 patients who
underwent ASD closure with surgery (n = 61) or an
Amplatzer device (n = 61) during a 1-year interval
beginning May 1997. Their series begins with the first
patient to undergo device closure in their institution.
Although this evaluation was prospective, the patients
were not randomized. The patients undergoing surgery
were older and had larger defects and larger shunts. In
fact, the surgical series essentially consisted of those
patients in whom device closure was not possible. In
addition, the median age of the patients in both groups
was much older than that of the usual patient currently
undergoing ASD closure. The ASD closure rate was
98% in each group, and there were no deaths. Two
patients undergoing surgical treatment had significant
complications, and in 1 patient the Amplatzer device
embolized, requiring surgical retrieval. Length of stay
was shorter in the patients receiving the Amplatzer
device (3 days) than in those treated surgically (8 days).
On the basis of the similar outcomes, the absence of
need for blood products, and the decreased length of
stay, the authors conclude that the Amplatzer device is
preferable to surgical closure of ASDs.
Despite the fact that the series are concurrent and
from the same institution, the report is flawed by the
fact that the 2 groups are not comparable, as is pointed
out by the authors. True randomization into compara-
ble series could have been achieved by including only
those patients who were suitable for either surgical or
device closure, and the results would have been more
meaningful. Most patients undergoing surgical closure
of ASD now are discharged in 3 days or less, and it is
unfair to use decreased length of stay in this series as a
reason for the superiority of the Amplatzer device.
However, in our institution, as noted below, most
patients receiving the device are discharged in 24
hours. The authors have fairly presented one of the
major complications of device closure, that is, emboli-
zation. Although uncommon, it is potentially the cause
of a very unsatisfactory outcome (stroke or death) in a
patient with a relatively benign defect. Despite these
criticisms, the authors have indeed demonstrated the
ability to successfully close secundum ASDs in about
half of the patients with this problem.
At the Medical University of South Carolina over the
past 23 months, 60 patients (aged 2-75 years) have under-
gone successful device closure of ASDs, and 97% were
discharged in less than 24 hours (W. Radtke, personal
communication). No significant complications have
occurred. During the same interval, 16 patients were eval-
uated by echocardiography (without the need for
catheterization, as in the series reported by Berger and
associates) and were believed to be unsuitable for device
closure. Because catheter device closure is much less
invasive, this approach probably will become increasing-
ly popular with pediatric cardiologists, patients, and fam-
ilies. With further experience and device evolution, this
technique will become applicable in a larger proportion
of patients with these defects than the 50% reported here.
It is likely, however, that a significant subset will contin-
ue to have defects unsuitable for device closure; thus sur-
gical intervention will still be required in that group.
Surgical closure should continue to provide excellent
results as in the past, but less invasive techniques offer the
possibility of decreasing morbidity.




It has been more than 20 years since the first report
of successful transcatheter device closure of atrial sep-
tal defects (ASDs).1 In the past decade, at least 6 dif-
ferent devices have been in widespread clinical trials;
several are now approved for use in many countries.
Past reports have compared catheter closure of ASDs
with historical surgical series. Berger and associates
are to be commended, because theirs is the first study
in which an attempt has been made to compare concur-
rent results of surgical and device closure of ASDs.
Surgery and device closure were each performed on 61
patients. Complications and efficacy of the 2 proce-
dures were similar at hospital discharge except for a
higher incidence of postprocedure atrial arrhythmias in
the surgical group.
The limitations of this study highlight the difficulties
in performing such a comparison at 1 center. The sur-
gical group was composed entirely of patients who
were deemed inappropriate for the Amplatzer device,
in most cases because their ASDs were too large or had
an inadequate rim of septum to secure the device. Over
two thirds of the patients who ultimately underwent
surgical closure had previously gone to the catheteriza-
tion laboratory with the intent of device closure. Not
surprisingly, patients who underwent surgery were
older, had larger defects, and had bigger shunts than
those who underwent device closure. The differences
between the 2 treatment groups are of more than acad-
emic importance. As the authors note, they may be
